Crinetics Pharmaceuticals... (CRNX)
NASDAQ: CRNX
· Real-Time Price · USD
35.61
1.36 (3.97%)
At close: Sep 05, 2025, 3:59 PM
36.00
1.10%
After-hours: Sep 05, 2025, 07:37 PM EDT
3.97% (1D)
| Bid | 33.71 |
| Market Cap | 3.35B |
| Revenue (ttm) | 1.39M |
| Net Income (ttm) | -369.83M |
| EPS (ttm) | -4.05 |
| PE Ratio (ttm) | -8.79 |
| Forward PE | -6.85 |
| Analyst | Buy |
| Ask | 36 |
| Volume | 1,387,055 |
| Avg. Volume (20D) | 867,772 |
| Open | 34.39 |
| Previous Close | 34.25 |
| Day's Range | 34.37 - 35.92 |
| 52-Week Range | 24.10 - 62.53 |
| Beta | 0.28 |
About CRNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Crinetics Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
-3.69%
CRNX stock has given up its prior gain. Crinetics ...
Unlock content with
Pro Subscription
4 weeks ago
-3.69%
Crinetics Pharmaceuticals shares are trading higher after the company reported a Q2 revenue beat and announced the Palsonify NDA is on track.
3 weeks ago · seekingalpha.com
Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call TranscriptCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Alan S. Krasner - Corporate Participant Chief Endocrinologist - Corporate...
4 weeks ago · fool.com
Crinetics (CRNX) Q2 Revenue Jumps 150%Crinetics (CRNX) Q2 Revenue Jumps 150%
